The rapid targeting and high tumor-background contrast of PSMA-Cy5 demonstrated that PSMA ligand-mediated prostate cancer targeted fluorescence imaging has high potential value, with important significance and value in basic scientific research and intraoperative navigation in clinical surgery. Here, FOLH1 is linked to prostate carcinoma.